PhaseBio Pharmaceuticals Inc: 8-K filed May 30, 2023

Form type

8-K

Filing date

May 30, 2023

Accession number

0001169245-23-000035

Filer

PhaseBio Pharmaceuticals Inc (CIK 1169245)